[This English translation is an abridged version of the original notice in Japanese. In the event of any discrepancy, the Japanese version prevails.]
December 9, 2025
Trade name: Noevir Holdings Co., Ltd.
Listing: Tokyo Stock Exchange, Prime Market (Code Number: 4928) Representative: Takashi Okura, President and CEO
Address: 6-13-1 Minatojima-Nakamachi, Chuo-ku, Kobe
Notice of Resolution of the 15th Annual General Meeting of ShareholdersThank you for your continued support for Noevir Holdings.
We hereby notify you of the following report and resolution made at the 15th Annual General Meeting of Shareholders, held today.
Thank you for your attention.
-
Matters to Report: Business report for the 15th business year (October 1, 2024 to September 30, 2025), consolidated financial statements, other financial report documents, and audit report on consolidated financial statements by the accounting auditor and Audit & Supervisory Board.
The above information was reported.
- Matters for resolution: Proposal 1 Partial Amendments to the Articles of Incorporation
This item was approved and resolved as originally proposed.
Proposal 2 Appointment of 13 DirectorsThis item was approved and resolved as originally proposed.
13 Directors, Mr. Hiroshi Okura, Mr. Takashi Okura, Mr. Ikkou Yoshida, Mr. Takeshi Okura, Mr. Kozo Matsushita, Mr. Akihiro Keyari, Mr. Ryo Tsuchida, Ms. Maho Kinami, Ms. Emima Abe, Ms. Mari Ishimitsu, Ms. Haruhi Kuroda, Ms. Emi Kanagasaki and Ms. Mari Tomita were appointed and assumed their offices.
Proposal 3 Appointment of one Audit & Supervisory Board MemberThis item was approved and resolved as originally proposed.
Ms. Kayo Sato was appointed as an Audit & Supervisory Board Member and assumed their offices.
Proposal 4 Revision of Remuneration Amount for DirectorsThis item was approved and resolved as originally proposed.
